Sam-A-Pharm Co Ltd
009300
Company Profile
Business description
Sam-A-Pharm Co Ltd is a South Korea-based company that engages in the manufacturing and selling of pharmaceuticals. The group manufactures respiratory system, antibiotics, skin system, digestive system, antipyretics, analgesics, anti-inflammatory drugs, circulatory endocrine system, general medicines, and health functional foods, and main products include Citus, Codenal, Hebron, Setofen, Tantum, Neocetin, Beforin, Geod-ak, Atok, Ridomex, and Normachu tablets.
Contact
49 Donghwa Industrial Complex-ro
Munmak-eup
Gangwon-do
Wonju-si
KORT: +82 220567200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
316
Stocks News & Analysis
stocks
Is this still an ASX share to own forever?
Find out how this defensive player has fared after earnings.
stocks
After earnings, is Nvidia stock a buy, a sell, or fairly valued?
No signs of a slowdown in demand for Nvidia’s chips, and the long-term picture looks bright.
stocks
Short-term pain for long-term gain for undervalued ASX share
Cost reductions lower our profit estimates but should lead to improved long-term outcomes.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,076.70 | 36.50 | 0.40% |
| CAC 40 | 7,719.71 | 65.46 | 0.86% |
| DAX 40 | 23,594.80 | 107.47 | 0.46% |
| Dow JONES (US) | 45,271.23 | 24.58 | -0.05% |
| FTSE 100 | 9,177.99 | 61.30 | 0.67% |
| HKSE | 25,309.98 | 33.45 | -0.13% |
| NASDAQ | 21,497.73 | 218.10 | 1.02% |
| Nikkei 225 | 42,388.58 | 449.69 | 1.07% |
| NZX 50 Index | 13,127.96 | 53.15 | 0.41% |
| S&P 500 | 6,448.26 | 32.72 | 0.51% |
| S&P/ASX 200 | 8,807.40 | 40.10 | 0.46% |
| SSE Composite Index | 3,784.79 | 28.77 | -0.75% |